BACKGROUND: No information is available about the financial impact of central venous catheter (CVC)-associated bloodstream infection (BSI) in Mexico. OBJECTIVE: To calculate the costs associated with BSI in intensive care units (ICUs) in Mexico City. DESIGN: An 18-month (June 2002 through November 2003), prospective, nested case-control study of patients with and patients without BSI. SETTING: Adult ICUs in 3 hospitals in Mexico City. PATIENTS AND METHODS: A total of 55 patients with BSI (case patients) and 55 patients without BSI (control patients) were compared with respect to hospital, type of ICU, year of hospital admission, length of ICU stay, sex, age, and mean severity of illness score. Information about the length of ICU stay was obtained prospectively during daily rounds. The daily cost of ICU stay was provided by the finance department of each hospital. The cost of antibiotics prescribed for BSI was provided by the hospitals' pharmacy departments. RESULTS: For case patients, the mean extra length of stay was 6.1 days, the mean extra cost of antibiotics was US dollars 598, the mean extra hospital cost was US dollars 11,591, and the attributable extra mortality was 20%. CONCLUSIONS: In this study, the duration of ICU stay for patients with central venous catheter-associated BSI was significantly longer than that for control patients, resulting in increased healthcare costs and a higher attributable mortality. These conclusions support the need to implement preventive measures for hospitalized patients with central venous catheters in Mexico.
BACKGROUND: No information is available about the financial impact of central venous catheter (CVC)-associated bloodstream infection (BSI) in Mexico. OBJECTIVE: To calculate the costs associated with BSI in intensive care units (ICUs) in Mexico City. DESIGN: An 18-month (June 2002 through November 2003), prospective, nested case-control study of patients with and patients without BSI. SETTING: Adult ICUs in 3 hospitals in Mexico City. PATIENTS AND METHODS: A total of 55 patients with BSI (case patients) and 55 patients without BSI (control patients) were compared with respect to hospital, type of ICU, year of hospital admission, length of ICU stay, sex, age, and mean severity of illness score. Information about the length of ICU stay was obtained prospectively during daily rounds. The daily cost of ICU stay was provided by the finance department of each hospital. The cost of antibiotics prescribed for BSI was provided by the hospitals' pharmacy departments. RESULTS: For case patients, the mean extra length of stay was 6.1 days, the mean extra cost of antibiotics was US dollars 598, the mean extra hospital cost was US dollars 11,591, and the attributable extra mortality was 20%. CONCLUSIONS: In this study, the duration of ICU stay for patients with central venous catheter-associated BSI was significantly longer than that for control patients, resulting in increased healthcare costs and a higher attributable mortality. These conclusions support the need to implement preventive measures for hospitalized patients with central venous catheters in Mexico.
Authors: V D Rosenthal; B Ramachandran; W Villamil-Gómez; A Armas-Ruiz; J A Navoa-Ng; L Matta-Cortés; M Pawar; A Nevzat-Yalcin; M Rodríguez-Ferrer; R D Yıldızdaş; A Menco; R Campuzano; V D Villanueva; L F Rendon-Campo; A Gupta; O Turhan; N Barahona-Guzmán; O O Horoz; P Arrieta; J M Brito; M C V Tolentino; Y Astudillo; N Saini; N Gunay; G Sarmiento-Villa; E Gumus; A Lagares-Guzmán; O Dursun Journal: Infection Date: 2012-02-28 Impact factor: 3.553
Authors: Hail M Al-Abdely; Areej Dhafer Alshehri; Victor Daniel Rosenthal; Yassir Khidir Mohammed; Weam Banjar; Pablo Wenceslao Orellano; Abdullah Mufareh Assiri; Nahla Moustafa Abedel Kader; Hessa Abdullah Al Enizy; Diaa Abdullah Mohammed; Duaa Khalil Al-Awadi; Analen Fabros Cabato; Maria Wasbourne; Randa Saliya; Rosita Gasmin Aromin; Evangelina Balon Ubalde; Hanan Hanafy Diab; Modhi Abdullah Alkamaly; Nawal Mohammed Alanazi; Ibtesam Yahia Hassan Assiry; Apsia Musa Molano; Celia Flores Baldonado; Mohamed Al-Azhary; Sharifa Al Atawi; Apsia Musa Molano; Fatima Mohammad Al Adwani; Arlu Marie Casuyon Pahilanga; Raslan Nakhla; Fatma Mohammad Al Adwani; Deepa Sasithran Nair; Grace Sindayen; Annalyn Amor Malificio; Najla Jameel Helali; Haya Barjas Al Dossari; Ashraf Kelany; Abdulmajid Ghowaizi Algethami; Leigh Yanne; Avigail Tan; Sheema Babu; Shatha Mohammad Abduljabbar; Syed Zahid Bukhari; Roaa Hasan Basri; Jeyashri Jaji Mushtaq; Hala Rushdi; Abdullah Abdulaziz Turkistani; Jerlie Mae Gonzales Celiz; Mohammed Abdullah Al Raey; Ibrahim Am Al-Zaydani Asiri; Saeed Ali Aldarani; Elizabeth Laungayan Cortez; Nadia Lynette Demaisip; Misbah Rehman Aziz; Ali Omer Abdul Aziz; Batool Al Manea; Eslam Samy; Mervat Al-Dalaton; Mohammed Jkedeb Alaliany Journal: J Infect Prev Date: 2016-10-22
Authors: Manuel S Rangel-Frausto; Francisco Higuera-Ramirez; Jose Martinez-Soto; Victor D Rosenthal Journal: Ann Clin Microbiol Antimicrob Date: 2010-02-02 Impact factor: 3.944
Authors: John R Prowle; Jorge E Echeverri; E Valentina Ligabo; Norelle Sherry; Gopal C Taori; Timothy M Crozier; Graeme K Hart; Tony M Korman; Barrie C Mayall; Paul D R Johnson; Rinaldo Bellomo Journal: Crit Care Date: 2011-03-21 Impact factor: 9.097